Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
US6090811A · kind A · utility
6Cited by
5References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 16, 1999 |
| Grant date | Jul 18, 2000 |
| Priority date | — |
| Expiry date | Jul 16, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel use for the class of biologically active bis-heterocyclic, e.g., bis-indole alkaloid compounds, which have been named topsentins, bromotopsentins, homocarbonyltopsentins, nortopsentins, hamacanthins, bis-indole ethylamines, or dragmacidins, pharmaceutical compositions containing the compounds, methods of producing the compounds, and methods of using the compounds are disclosed. Specifically, the novel utility pertains to the anti-neurogenic inflammatory properties exhibited by the bis-indole compounds and their analogs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.